Market Size of Europe Esoteric Testing Industry
![Europe Esoteric Testing Market Summary](https://s3.mordorintelligence.com/europe-esoteric-testing-market/1715759784799-europe-esoteric-testing-market-Market-Summary.png)
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Market Size (2024) | USD 7.80 Billion |
Market Size (2029) | USD 13.23 Billion |
CAGR (2024 - 2029) | 11.23 % |
Market Concentration | High |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Esoteric Testing Market Analysis
The Europe Esoteric Testing Market size is estimated at USD 7.80 billion in 2024, and is expected to reach USD 13.23 billion by 2029, growing at a CAGR of 11.23% during the forecast period (2024-2029).
The European esoteric testing market is anticipated to grow with the rising burden of chronic diseases, rare diseases, and increasing research expenditure. The rising prevalence of chronic illnesses and uncommon ailments in Europe is spurring the need for specialized testing. The widespread occurrence of diseases such as cancer, infectious agents, and unusual genetic conditions calls for cutting-edge diagnostic techniques to enable precise and timely recognition, contributing to market growth.
The region has an increasing burden of several chronic and rare diseases that require esoteric testing to be diagnosed on time. For instance, as per the International Diabetes Federation (IDF), in February 2022, over 4.47 million adults were reported to have diabetes in the total adult population in Italy, which was equivalent to a prevalence rate of 9.9%. It was also stated that over 1.2 million children and adolescents aged 19 years or less were reported to have type-1 diabetes. Thus, the growing burden of type I and type II diabetes is expected to increase demand for diagnosis with esoteric testing, which is likely to support the growth of the market.
Similarly, according to the data updated by the Spanish Network of Cancer Registries (REDECAN) in January 2023, approximately 279,260 new cases of cancer were expected to occur in Spain by the end of 2023, out of which 42,721 new cases of colorectal cancer, 31,282 cases of lung cancer, and 21,694 cases of urinary bladder cancer. Thus, with the vast patient base of chronic patients, the demand for esoteric tests is expected to increase for the timely or early diagnosis of underlying diseases, boosting the market’s growth during the forecast period.
Furthermore, recent developments by service providers are expected to increase the availability of esoteric testing in the region, which is likely to boost the market’s growth. For instance, in April 2022, Minaris Medical obtained the European Union In Vitro Diagnostic Medical Devices Regulation certification for fecal occult blood test reagents. Similarly, in November 2023, Arup Laboratories achieved the Conformité Européenne (CE) certification for the single-site use of AAV5 DetectCDx, aligning with the European Union's In Vitro Diagnostic Medical Devices Regulation. Developed in collaboration with BioMarin Pharmaceutical Inc., AAV5 DetectCDx functions as a companion diagnostic, aiding in the identification of adult patients eligible for BioMarin's groundbreaking gene therapy for severe hemophilia A, valoctocogene roxaparvovec-rvox (ROCTAVIAN). Thus, the launch and approval of innovative esoteric tests in the market are expected to contribute to the market's growth during the forecast period.
Therefore, owing to the factors above, the market studied is anticipated to grow during the forecast period. However, the stringent regulatory scenario is likely to impede the market’s growth.
Europe Esoteric Testing Industry Segmentation
As per the scope of the report, esoteric testing is used to analyze and detect rare substances and molecules. The European esoteric testing market is segmented by test type, technology, and geography. By test type, the market is segmented into endocrinology, infectious disease, oncology, neurology, toxicology, and other test types. By technology, the market is segmented into flow cytometry, chemiluminescence immunoassay, mass spectrometry, radioimmunoassay, and other technologies. By geography, the market is segmented into Germany, the United Kingdom, France, Italy, Spain, and Rest of Europe. The report offers the value (USD) for all the above segments.
By Test Type | |
Endocrinology | |
Infectious Disease | |
Oncology | |
Neurology | |
Toxicology | |
Other Test Types |
By Technology | |
Flow Cytometry | |
Chemiluminescence Immunoassay | |
Mass Spectrometry | |
Radio Immunoassay | |
Other Technologies |
By Geography | |
Germany | |
United Kingdom | |
France | |
Italy | |
Spain | |
Rest of Europe |
Europe Esoteric Testing Market Size Summary
The European esoteric testing market is poised for substantial growth, driven by the increasing prevalence of chronic and rare diseases that necessitate specialized diagnostic approaches. The demand for esoteric testing is fueled by the need for precise and timely diagnosis of conditions such as cancer, diabetes, and uncommon genetic disorders. This demand is further bolstered by rising research expenditures and advancements in diagnostic technologies. The market is characterized by a fragmented landscape with numerous regional players employing strategies like expansion, acquisition, and new product launches to maintain competitiveness. Notable companies in this space include Eurofins Scientific, Nordic Laboratories, and Buhlmann Diagnostics Corp, among others.
The market's expansion is supported by recent regulatory approvals and certifications for innovative diagnostic tests, enhancing the availability and application of esoteric testing across Europe. Initiatives such as the EU Beating Cancer Plan underscore the region's commitment to improving cancer detection and treatment outcomes, further propelling market growth. The United Kingdom, in particular, is expected to experience significant growth due to its advanced medical infrastructure and ongoing research in early disease diagnosis. Despite the promising growth trajectory, the market faces challenges from stringent regulatory environments that could impede progress. Overall, the European esoteric testing market is set to grow robustly, driven by the increasing need for advanced diagnostic solutions and supportive regulatory frameworks.
Europe Esoteric Testing Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Burden of Chronic Diseases and Rare Diseases
-
1.2.2 Increasing Research Expenditure
-
-
1.3 Market Restraints
-
1.3.1 Stringent Regulatory Framework
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Test Type
-
2.1.1 Endocrinology
-
2.1.2 Infectious Disease
-
2.1.3 Oncology
-
2.1.4 Neurology
-
2.1.5 Toxicology
-
2.1.6 Other Test Types
-
-
2.2 By Technology
-
2.2.1 Flow Cytometry
-
2.2.2 Chemiluminescence Immunoassay
-
2.2.3 Mass Spectrometry
-
2.2.4 Radio Immunoassay
-
2.2.5 Other Technologies
-
-
2.3 By Geography
-
2.3.1 Germany
-
2.3.2 United Kingdom
-
2.3.3 France
-
2.3.4 Italy
-
2.3.5 Spain
-
2.3.6 Rest of Europe
-
-
Europe Esoteric Testing Market Size FAQs
How big is the Europe Esoteric Testing Market?
The Europe Esoteric Testing Market size is expected to reach USD 7.80 billion in 2024 and grow at a CAGR of 11.23% to reach USD 13.23 billion by 2029.
What is the current Europe Esoteric Testing Market size?
In 2024, the Europe Esoteric Testing Market size is expected to reach USD 7.80 billion.